top of page

Middlemen's role in drug shortages probed

The Federal Trade Commission is exploring how drug distributors and group-purchasing organizations may be contributing to ongoing shortages of generic drugs at health care facilities.

Why it matters: It's the latest effort to untangle a complex web of factors driving high levels of shortages, which have affected cancer drugs and antibiotics, among others. ...


bottom of page